Are patients with stage III non-small cell lung cancer treated with chemoradiotherapy at risk for cardiac events? Results from a retrospective cohort study

Juliette Degens*, D. De Ruysscher, Ruud Houben, Bastiaan Kietselaer, Gerben Bootsma, Lizza Hendriks, Ellen Huijbers, Annemie Schols, Anne-Marie C. Dingemans

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number036492
Number of pages7
JournalBMJ Open
Volume10
Issue number9
DOIs
Publication statusPublished - 2020

Keywords

  • adult cardiology
  • chemotherapy
  • thoracic medicine
  • respiratory tract tumours
  • adult oncology
  • DOSE-ESCALATION TRIALS
  • RADIOTHERAPY
  • SURVIVAL
  • TOXICITY
  • THERAPY
  • NSCLC

Cite this